Sponsor pipeline

Adicet Therapeutics clinical trial pipeline

Get alerts when Adicet Therapeutics's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1
2
Phase 1/2
2
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT06480565 A Phase 1/2 Trial of ADI-270 in ccRCC Clear Cell Renal Cell Carcinoma Active, Not Recruiting 2026-09-10
NCT07793435 A Phase 1/2 Trial of ADI-212 in mCRPC Prostate Cancer Metastatic Not Yet Recruiting 2026-09-10
Phase 1
NCT07100873 A Phase 1 Study of ADI-001 in Rheumatoid Arthritis Rheumatoid Arthritis (RA) Recruiting 2025-12-08
NCT06375993 A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune… Lupus Nephritis Enrolling by Invitation 2026-03-19
Not specified
NCT04911478 Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells Lymphoma, Follicular Active, Not Recruiting 2026-04-09

Disease areas by active trials

DLBCL (1) · Follicular Lymphoma (1) · Kidney Cancer (1) · Lupus (SLE) (1) · Mantle Cell Lymphoma (1) · Non-Hodgkin Lymphoma (1) · Prostate Cancer (1) · Rheumatoid Arthritis (1) · Scleroderma (1)

Get alerts when Adicet Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free